Patterns and Treatment Strategies of Osimertinib Resistance in T790M-Positive Non-Small Cell Lung Cancer: A Pooled Analysis

INTRODUCTION: Osimertinib resistance is inevitable. The purpose of this study was to explore the predictive value of pretreatment clinical characteristics in T790M-positive non-small cell lung cancer NSCLC patients for the resistance pattern of osimertinib during tumor progression as well as the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chunsheng, Zhao, Kewei, Hu, Shanliang, Li, Minghuan, Song, Yipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982860/
https://www.ncbi.nlm.nih.gov/pubmed/33763349
http://dx.doi.org/10.3389/fonc.2021.600844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982860/
https://www.ncbi.nlm.nih.gov/pubmed/33763349
http://dx.doi.org/10.3389/fonc.2021.600844

Ejemplares similares